The drug industry’s stake in Trumpcare is bigger than you think

(By Dylan Scott for STAT)

WASHINGTON — The upcoming fight over repealing and replacing the Affordable Care Act1 promises to shake up hospitals and insurers, but drug makers also stand to gain — or lose — a lot. Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or